Latest Insider Transactions at Sangamo Therapeutics, Inc (SGMO)
This section provides a real-time view of insider transactions for Sangamo Therapeutics, Inc (SGMO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SANGAMO THERAPEUTICS, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SANGAMO THERAPEUTICS, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2020
|
Sung Lee EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,042
-5.38%
|
$45,378
$9.77 P/Share
|